Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults ≥ 50 Years of Age.

已完结 10 由猪猪侠发布于 2026/8/5 8:00:30

DOI:10.1093/cid/ciag208
作者：Jean-Fran?ois Roussy,?Patrick Dennis,?Anil K Gupta,?Garry Wallace,?Alexander Abitbol,?Naresh Aggarwal,?Joseph G Surber,?Theodore Lee,?Brian A Smith,?Catherine Gérard,?Hiwot Amare Hailemariam,?Marie-P
文献类型：期刊论文
补充材料：只需要正文

Oxford University Press

Abstract：Background: Co-administration of AS01E-adjuvanted respiratory syncytial virus vaccine (adjuvanted RSVPreF3) and AS01B-adjuvanted recombinant herpes zoster subunit vaccine (RZV), although not

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Construction of Z-scheme C-LaFeO3/Co-doped g-C3N4 heterojunction for synergistic photocatalysis-PMS activation in antibiotic degradation